454 related articles for article (PubMed ID: 28404744)
1. The role of CB
Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
[TBL] [Abstract][Full Text] [Related]
2. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
3. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
4. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
5. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
Wang J; Zhang X; Yang C; Zhao S
Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
[TBL] [Abstract][Full Text] [Related]
6. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
Lau BK; Drew GM; Mitchell VA; Vaughan CW
Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
[TBL] [Abstract][Full Text] [Related]
8. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
[TBL] [Abstract][Full Text] [Related]
11. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
[TBL] [Abstract][Full Text] [Related]
13. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
Bernal-Chico A; Canedo M; Manterola A; Victoria Sánchez-Gómez M; Pérez-Samartín A; Rodríguez-Puertas R; Matute C; Mato S
Glia; 2015 Jan; 63(1):163-76. PubMed ID: 25130621
[TBL] [Abstract][Full Text] [Related]
14. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
[TBL] [Abstract][Full Text] [Related]
17. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.
Alhamoruni A; Wright KL; Larvin M; O'Sullivan SE
Br J Pharmacol; 2012 Apr; 165(8):2598-610. PubMed ID: 21745190
[TBL] [Abstract][Full Text] [Related]
19. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
20. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
